Tonie E Rocke Selected Research

Vaccines

12/2021	Impact of Molecular Modifications on the Immunogenicity and Efficacy of Recombinant Raccoon Poxvirus-Vectored Rabies Vaccine Candidates in Mice.
1/2021	Moderate Susceptibility to Subcutaneous Plague (Yersinia pestis) Challenge in Vaccine-Treated and Untreated Sonoran Deer Mice (Peromyscus maniculatus sonoriensis) and Northern Grasshopper Mice (Onychomys leucogaster).
1/2020	Rabies Outbreak in Captive Big Brown Bats (Eptesicus fuscus) Used in a White-Nose Syndrome Vaccine Trial.
12/2019	Fluorescent biomarkers demonstrate prospects for spreadable vaccines to control disease transmission in wild bats.
1/2018	Impact of Sylvatic Plague Vaccine on Non-target Small Rodents in Grassland Ecosystems.
1/2018	Factors Influencing Uptake of Sylvatic Plague Vaccine Baits by Prairie Dogs.
10/2017	Protection of bats (Eptesicus fuscus) against rabies following topical or oronasal exposure to a recombinant raccoon poxvirus vaccine.
1/2017	Sylvatic Plague Vaccine Partially Protects Prairie Dogs (Cynomys spp.) in Field Trials.
1/2017	Burrow Dusting or Oral Vaccination Prevents Plague-Associated Prairie Dog Colony Collapse.
10/2016	Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tonie E Rocke Research Topics

Disease

23	Plague (Bubonic Plague) 01/2021 - 03/2003
12	Infections 01/2023 - 03/2003
9	Rabies (Hydrophobia) 01/2022 - 09/2012
2	Virus Diseases (Viral Diseases) 10/2016 - 08/2009
1	Mpox (monkeypox) 01/2023
1	Communicable Diseases (Infectious Diseases) 12/2019
1	Neglected Diseases 10/2017
1	Vaccinia 10/2016
1	Inflammation (Inflammations) 10/2011
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 05/2011
1	Bites and Stings (Sting) 01/2010

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 12/2021 - 03/2003
9	AntigensIBA 01/2018 - 07/2004
8	Proteins (Proteins, Gene)FDA Link 10/2014 - 06/2004
5	Neutralizing AntibodiesIBA 01/2022 - 10/2016
4	Plague VaccineIBA 01/2018 - 09/2012
4	LuciferasesIBA 10/2017 - 08/2009
3	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2022 - 12/2021
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 10/2017
2	Viral DNAIBA 10/2016 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 04/2014 - 07/2011
1	Antiviral Agents (Antivirals)IBA 01/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	Virulence Factors (Pathogenicity Factors)IBA 01/2023
1	Nucleic AcidsIBA 01/2022
1	NucleoproteinsIBA 01/2020
1	Viral ProteinsIBA 01/2020
1	InsecticidesIBA 01/2017
1	AntibodiesIBA 04/2014
1	N 30IBA 10/2013
1	CalbindinsIBA 10/2011
1	Immunologic Factors (Immunomodulators)IBA 10/2011
1	Thromboplastin (Tissue Factor)IBA 10/2011
1	Thrombopoietin (c-mpl Ligand)IBA 10/2011
1	CD40 Ligand (CD40L)IBA 10/2011
1	rhodamine BIBA 07/2011
1	Prion ProteinsIBA 05/2011
1	aluminum sulfate (alum)IBA 01/2010
1	Vaccine AdjuvantsIBA 01/2010
1	Recombinant ProteinsIBA 06/2004
1	Synthetic Vaccines (Recombinant Vaccines)IBA 03/2003

Therapy/Procedure

1	Transcutaneous Electric Nerve Stimulation (TENS) 10/2017
1	Injections 09/2012